A Trial of a Transglutaminase 2 Inhibitor in Celiac Disease. Reply

N Engl J Med. 2021 Oct 14;385(16):e57. doi: 10.1056/NEJMc2112688.

Authors

Detlef Schuppan¹, Markku Mäki², Knut E A Lundin³

Affiliations

¹ Mainz University Hospital, Mainz, Germany [email protected].
² Tampere University Hospital, Tampere, Finland.
³ Oslo University Hospital, Oslo, Norway.

PMID: 34644485
DOI: 10.1056/NEJMc2112688

No abstract available

Publication types

Letter
Comment

MeSH terms

Celiac Disease* / drug therapy
GTP-Binding Proteins
Humans
Protein Glutamine gamma Glutamyltransferase 2
Transglutaminases

Substances

Protein Glutamine gamma Glutamyltransferase 2
Transglutaminases
GTP-Binding Proteins